The Daily Market Rhapsody: Unpacking Today's Big Swings and Startling Surprises A Pharmaceutical Titan's Bold Bet: Novartis Swallows Avidity in a $12 Billion Quest for Genetic Breakthroughs The Whisper Becomes a Roar: Why Novartis Needs Avidity’s RNA Revolution, Now More Than Ever The Biotech Gambit: Novartis Reportedly Eyes Avidity in a High-Stakes Acquisition